Table 1.

Demographics information of the all accrued 12 patients, patient #2 did not receive ¹⁸F-VM4-037 injection and PET/CT imaging

Patient demographics
Subject #	Gender	Age	Known hereditary RCC mutation	Clinical stage	Histology	Grade	Tumor size (cm)
1	F	46	Yes (VHL)	TONOMO	Renalcyst	n/a	3.6
2	M	28	Yes (VHL)	T1aNOMO	ccRCC	2	3.4
3	M	44	No	T3aNOM1	ccRCC with sarcomatoid differentiation	4	6.89
4	F	60	No	T3aNOM1	ccRCC with sarcomatoid features	4	9.3
5	M	76	Yes (VHL)	T1aNOMO	ccRCC	2	4.0
6	M	57	Yes (VHL)	T1aNOMO	ccRCC	2	3.3
7	M	52	No	T1aNOMO	ccRCC	2	2.7
8	M	60	No	T1aNOMO	ccRCC	2	3.7
9	F	62	No	T2NOM1	ccRCC	2	2.0
10	M	71	No	T1aNOMO	ccRCC	2	3.4
11	M	78	No	T1bNOMO	ccRCC	3	5.8
12	M	59	Yes (VHL)	T1aNOMO	ccRCC	2	3.5